Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission.
嚴重肥胖患者住院期間使用胰高血糖素樣肽-一受體類似物治療的減重效果。
Cureus 2023-03-04
The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials.
GLP-1類似物對肥胖成人的食慾參數、胃排空、食物偏好和味覺的功效:隨機對照試驗的系統性回顧。
Diabetes Metab Syndr Obes 2023-03-10
Dysglycemia Shapes Visceral Adipose Tissue's Response to GIP, GLP-1 and Glucagon in Individuals with Obesity.
肥胖者血糖異常對GIP、GLP-1和葡萄糖素影響內臟脂肪組織的反應。
Metabolites 2023-05-29
Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options.
內臟脂肪組織與殘餘心血管風險:病理連結與新治療選項。
Front Cardiovasc Med 2023-08-15
The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
GLP-1受體激動劑對有或無糖尿病及非酒精性脂肪肝成人族群的內臟脂肪和肝臟異位脂肪的影響:系統性回顧與荟萃分析。
PLoS One 2023-09-01
Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study.
阻塞性睡眠呼吸暫停症患者中,持續正壓呼吸治療但非 GLP1 介導的體重減輕改善早期心血管疾病:一項隨機概念驗證研究。
Ann Am Thorac Soc 2024-03-04
The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review.
GLP-1受體激動劑對阻塞性睡眠呼吸暫停的影響:一項概覽性回顧。
Pharmacy (Basel) 2024-01-24
Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials.
糖尿病患者與非酒精性脂肪肝病或肥胖患者中胰高血糖素樣肽-1受體激動劑對脂肪積聚的影響:隨機對照試驗的系統性回顧和荟萃分析。
J Diabetes Complications 2024-05-21
Liraglutide improves adipose tissue remodeling and mitochondrial dynamics in a visceral obesity model induced by a high-fat diet.
Liraglutide 改善高脂飲食誘導的內臟肥胖模型中的脂肪組織重塑和粒線體動力學。
Curr Res Pharmacol Drug Discov 2024-06-07